TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2
Gynecologic Oncology Sep 05, 2017
Duan H, et al. – Study's aspiration was to illustrate the role of Ten–eleven translocation 1 (TET1) in epithelial ovarian cancer (EOC) development. By activating Wnt/β–catenin signaling inhibitors Dikkopf 1 (DKK1) and secreted Fzd receptor protein 2 (SFRP2), TET1 had potent tumor–suppressive effects in EOC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
